Gene Test Developed To Accurately Classify Brain Tumors, University of Pennsylvania Study

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Scientists at The Wistar Institute have developed a mathematical method for classifying forms of glioblastoma, an aggressive and deadly type of brain cancer, through variations in the way these tumor cells "read" genes. Their system was capable of predicting the subclasses of glioblastoma tumors with 92 percent accuracy. With further testing, this system could enable physicians to accurately predict which forms of therapy would benefit their patients the most.

Hey, check out all the engineering jobs. Post your resume today!

Back to news